Abstract CT030: STARTRK-NG: A phase 1/1b study of entrectinib in children and adolescents with advanced solid tumors and primary CNS tumors, with or without TRK, ROS1, or ALK fusions
暂无分享,去创建一个
C. Wetmore | G. Brodeur | A. Sabnis | P. Multani | Vanessa Esquibel | S. Shusterman | A. Desai | J. Foster | E. Basu | E. Fox | E. C. Maneval | Z. Hornby | Magaret Macy